Cancer awareness campaigns often focus on one disease at a time. For example, this past October, Breast Cancer Awareness Month educated the public on breast cancer symptoms, risk factors, and available resources. November takes a broader approach, featuring four campaigns: Neuroendocrine Tumors Awareness Month, Gastric Cancer Awareness Month, Lung Cancer Awareness Month, and Pancreatic Cancer Awareness Month.
Although these cancers differ, there is an important factor that connects several of them: inherited genetic risk. Certain genetic variants can increase a person’s likelihood of developing multiple types of cancer, which is why genetic testing is often a part of the wider cancer awareness conversation.
Understanding Cancer Risk
Cancer has many causes, and two people might develop the same form of cancer for completely different reasons. Age, lifestyle factors, and environmental exposures can all influence whether someone develops a certain type of disease. Inherited genetic variants are another piece of the puzzle, and their potential influence can extend beyond a single type of cancer.
November’s four cancer awareness initiatives illustrate this point. Some inherited genetic variants can increase stomach cancer risk, while others are associated with increased risks of lung or pancreatic cancer. Several of these genetic variants overlap, leading to an increased lifetime risk of two or more cancers. While the existence of a mutated gene doesn’t automatically lead to a cancer diagnosis, hereditary cancer testing can provide a clearer picture of one’s genetic profile.
Awareness campaigns like this November’s can provide a wealth of information about these diseases, including which symptoms to watch for and what to discuss with a healthcare provider. Healthcare providers often look at certain risk factors like family history of cancer when assessing whether to recommend earlier or more frequent screening. Hereditary cancer test results can give them more information to assess someone’s overall risk.
What Makes Hereditary Testing Different?
When it comes to cancer testing, treatment, and screening, different tests serve different purposes. Hereditary cancer testing is not the same as a screening procedure, which is designed to look for signs of cancer. Instead, it detects genetic variants associated with increased cancer risk. The distinction matters, as one person may have a genetic mutation and yet never develop cancer, while another may have no mutations and still get cancer.
One benefit of genetic testing is that it provides another source of information to consider alongside one’s personal and family medical history. Over the last few years, at-home testing programs have made genetic testing more accessible. jscreen, a national nonprofit public health initiative, is one of several organizations that offer hereditary cancer testing to individuals nationwide.
The program examines 63 genes associated with hereditary cancer syndromes and increased cancer risk. Participants can order a kit online, collect a saliva sample at home, and mail it to a clinical laboratory for testing, with results available within three to four weeks. They can also schedule a consultation with a certified genetic counselor to review their findings and discuss potential next steps with a healthcare provider.
As November’s cancer awareness campaigns have shown, one of the most important steps in the fight against cancer is education. Understanding inherited risks can help individuals and their healthcare providers make more informed decisions about screening and prevention. No matter which cancer is in the spotlight, hereditary cancer testing offers another way to better understand the factors that may influence an individual’s risk.

